{
     "PMID": "15036582",
     "OWN": "NLM",
     "STAT": "MEDLINE",
     "DCOM": "20040513",
     "LR": "20131121",
     "IS": "0304-3940 (Print) 0304-3940 (Linking)",
     "VI": "357",
     "IP": "2",
     "DP": "2004 Mar 4",
     "TI": "Milnacipran, a serotonin and noradrenaline reuptake inhibitor, suppresses long-term potentiation in the rat hippocampal CA1 field via 5-HT1A receptors and alpha 1-adrenoceptors.",
     "PG": "91-4",
     "AB": "Pharmacological characteristics of a serotonin (5-HT) and noradrenaline reuptake inhibitor (SNRI), milnacipran, in modulation of the synaptic plasticity were investigated. Milnacipran (30 mg/kg, i.p.) suppressed the long-term potentiation (LTP) in the hippocampal CA1 field of anesthetized rats. Milnacipran-induced suppression was reversed by pretreatment with the selective 5-HT1A receptor antagonist WAY 100635 (0.1 mg/kg, i.v.) or the alpha1-adrenoceptor antagonist prazosin (1 and 10 microg/rat, i.c.v.). The alpha2-adrenoceptor antagonist idazoxan (5 mg/kg, i.p.) did not influence the milnacipran-induced synaptic responses. These data suggest that the inhibitory effects of milnacipran on LTP induction are mediated via both 5-HT1A receptors and alpha1-adrenoceptors. In other words, functional interaction between the serotonergic and noradrenergic neuronal systems is involved in alteration of the hippocampal synaptic plasticity, which may be implicated in the SNRI-induced therapeutic effect on psychiatric disorders.",
     "FAU": [
          "Tachibana, Kaori",
          "Matsumoto, Machiko",
          "Togashi, Hiroko",
          "Kojima, Taku",
          "Morimoto, Yuji",
          "Kemmotsu, Osamu",
          "Yoshioka, Mitsuhiro"
     ],
     "AU": [
          "Tachibana K",
          "Matsumoto M",
          "Togashi H",
          "Kojima T",
          "Morimoto Y",
          "Kemmotsu O",
          "Yoshioka M"
     ],
     "AD": "Department of Anesthesiology and Critical Care Medicine, Hokkaido University Graduate School of Medicine, Kita-15, Nishi-7, Kita-ku, Sapporo 060-8638, Japan.",
     "LA": [
          "eng"
     ],
     "PT": [
          "Comparative Study",
          "Journal Article"
     ],
     "PL": "Ireland",
     "TA": "Neurosci Lett",
     "JT": "Neuroscience letters",
     "JID": "7600130",
     "RN": [
          "0 (Adrenergic Uptake Inhibitors)",
          "0 (Cyclopropanes)",
          "0 (Receptors, Adrenergic, alpha-1)",
          "0 (Serotonin Uptake Inhibitors)",
          "112692-38-3 (Receptor, Serotonin, 5-HT1A)",
          "G56VK1HF36 (milnacipran)",
          "X4W3ENH1CV (Norepinephrine)"
     ],
     "SB": "IM",
     "MH": [
          "Adrenergic Uptake Inhibitors/*pharmacology",
          "Animals",
          "Cyclopropanes/*pharmacology",
          "Hippocampus/drug effects",
          "Long-Term Potentiation/*drug effects/physiology",
          "Male",
          "Norepinephrine/*antagonists & inhibitors/*metabolism",
          "Rats",
          "Rats, Wistar",
          "Receptor, Serotonin, 5-HT1A/*physiology",
          "Receptors, Adrenergic, alpha-1/*physiology",
          "Serotonin Uptake Inhibitors/*pharmacology"
     ],
     "EDAT": "2004/03/24 05:00",
     "MHDA": "2004/05/14 05:00",
     "CRDT": [
          "2004/03/24 05:00"
     ],
     "PHST": [
          "2003/10/03 00:00 [received]",
          "2003/11/10 00:00 [revised]",
          "2003/11/13 00:00 [accepted]",
          "2004/03/24 05:00 [pubmed]",
          "2004/05/14 05:00 [medline]",
          "2004/03/24 05:00 [entrez]"
     ],
     "AID": [
          "10.1016/j.neulet.2003.11.016 [doi]",
          "S0304394003013399 [pii]"
     ],
     "PST": "ppublish",
     "SO": "Neurosci Lett. 2004 Mar 4;357(2):91-4. doi: 10.1016/j.neulet.2003.11.016.",
     "term": "hippocampus"
}